Risk of incontinence with transurethral resection of the prostate after radiation therapy for prostate cancer
β Scribed by Patel, Hetal; Peddada, Anuj V.; Zimmern, Philippe E.; Hernandez, Reynaldo; Kagan, Robert
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 64 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Background: It has been reported that transurethral resection of the prostate (TURP) after definitive radiation therapy for prostate cancer is associated with a significant risk of incontinence. The presumed reason for incontinence is external sphincter damage from TURP or pre-existing damage from either extension of prostate cancer or radiation therapy. Methods: We reviewed seven recent cases of TURP for bladder outlet obstruction in patients who had undergone radiation therapy for clinical stage T 3-4 M 0 N 0 adenocarcinoma of the prostate. All seven men progressed to either chronic retention or debilitating obstructive symptoms with weak peak flows from 3.4 to 5.1 cc/s (mean 4 cc/s). Each of them subsequently underwent a limited TURP. Results: Voiding symptoms were reduced in all patients and peak flows were improved to 6.3 to 20 cc/s (mean 14.8 cc/s) with mean follow-up 35 m. No patient developed stress urinary incontinence postoperatively.
Conclusion:
These results suggest that TURP can be performed successfully after radiation therapy with minimal risk of stress incontinence. J.
π SIMILAR VOLUMES
## Background: The authors analyzed retrospectively their institution's experience in treating patients with localized prostate carcinoma with external beam radiation therapy (ebrt) to determine the correlation of various biochemical failure (bf) definitions with clinical failure and cause specific
## BACKGROUND. The 1997 American Joint Committee on Cancer (AJCC) staging system condensed unilobular tumors into one entity and continues the use of both imaging and biopsy to alter classification status in T2 and T3 carcinomas. This study analyzes the biochemical freedom from disease recurrence